A technique using a commercially available optical tracking system helps counter motion artifacts in neurological PET studies, according to a study published in the June issue of the Journal of Nuclear Medicine.
A technique using a commercially available optical tracking system helps counter motion artifacts in neurological PET studies, according to a study published in the June issue of the Journal of Nuclear Medicine.
Brain PET examinations are lengthy, making head motion inside the scanner inevitable. This leads to poor resolution, if not erroneous data interpretation. Several schemes for motion correction have been proposed with varied degrees of success. But most have been tested only on phantoms or non-neurological studies.
Australian and German investigators assessed motion artifact correction in six human subjects undergoing PET scanning of neuroreceptor binding. They used a multiple-acquisition frame (MAF) method supported by a motion-tracking system that targets special body markers with infrared light. These markers are attached to a cap or gogglelike accessory that covers the patient's skull during scanning.
The MAF-based motion correction method successfully reduced blurry PET images and statistical noise from parametric maps, which involve data analysis charts displayed along with serial FDG-PET images.
The researchers monitored the effect of motion on parametric images of the brain's distribution volume ratio (DVR), a noninvasive method to look into the diagnosis and management of psychiatric disorders. DVR images correlate with the binding potential of the receptor ligand F-18 altanserin.
DVR images of F-18 altanserin PET scans showed a number of movement-related artifacts that appeared as discontinuities and small spots at the border between gray and white matter and at the outer border of gray matter. MAF eliminated all of these artifacts.
The MAF technique consists of short time frames recombined into a longer, motion-corrected sequence. But MAF isn't perfect. Neither coregistration nor scatter correction can take place if the time frames are too short. And the technique can make scanning and interpretation time-consuming. Further studies should examine the pros and cons of the MAF and similar methods and their impact on the interpretation of parametric PET images, the researchers said.
The motion-tracking device used in combination with motion-correction software and parametric DVR helped to improve brain PET considerably and to avoid calculation errors that are likely to occur using conventional methods, they said.
For more information from the Diagnostic Imaging archives:
Echocontrast augments usefulness of neurosonology
Prototype automated expert system aids Alzheimer's disease diagnosis
Boomers turn to PET to allay fears of Alzheimer's
FDG-PET can detect Alzheimer's disease at its earliest expression
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.